Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression
Active Grant Awarded Last action
- Award ID
- K23MH132900
- Recipient
-
The Mclean Hospital Corporation UEI MCKWJYCWNVN3
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $713,664
Award facts
- Assistance listing
- 93.24X Mental Health Research - Other Research
- Completion date 61% complete
- Place of performance
- Belmont, MA 02478, USA
Award details come from USAspending.gov.
Description
- Abstract
- The clinical high-risk (CHR) or "prodromal" framework has provided a platform for tracking the onset of psychosis and identifying the neurodevelopmental mechanisms of risk for this disorder. IT is now well established, however, that affective symptoms in CHR samples are essentially universal, persist longitudinally, and contribute to disability regardless of psychosis transition. Given the substantial neurobiological proximity of psychotic and affective disorders, the extent to which current biomarkers in CHR reflect risk for psychosis, common affective illness, or both remains largely unknown. Broadening the scope of detection to the early affective stages has potential to strengthen pathogenic models of psychosis by highlighting shared and unique vulnerability mechanisms while informing treatments that are relevant to a wider range of individuals. This study will identify shared and differential impairments of stress and reward processing among youth with psychosis-risk syndromes or early-stage depression (ESD). In a task-based fmri design, youth with CHR, ESD, or no psychopathology will complete a probabilistic reinforcement learning paradigm before and after an acute stress manipulation. Using an established computational model we will generate estimates of theoretically relevant learning parameters, compare them across groups, and relate them to neural and hormonal data. We hypothesize that the striatum represents a shared locus of reward-based dysfunction across the early and high-risk stages of psychosis and depression, but risk-specific differences may LIE within the prefrontal cortex. The results of this study will represent a significant step forward in our transdiagnostic understanding of emerging psychopathology, with implications for both generalizable and personalized intervention. By the end of the project period I will have established expertise in task-based fmri research, independence in computational modeling of behavior, and expert knowledge of the interplay between stress, reward, and neurodevelopment across mood and psychotic disorders. Together this will provide a unique combination of clinical and methodological expertise and prepare me for my long-term goal of improving preventative intervention through longitudinal research.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $178,416 | |
| Amendment | $178,416 | |
| Amendment | $178,416 | |
| Original award | $178,416 |
Quick answers
Who received award K23MH132900?
K23MH132900 was awarded to The Mclean Hospital Corporation by National Institute of Mental Health (National Institutes of Health) on November 16, 2023.
How much is award K23MH132900 worth?
$713,664 has been obligated on K23MH132900.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award